Fig. 9From: HIGD2A silencing impairs hepatocellular carcinoma growth via inhibiting mitochondrial function and the MAPK/ERK pathwayA model describing knockdown of HIGD2A attenuates hepatocellular carcinoma growth by causing mitochondrial dysfunction and the suppression of MAPK/ERK pathway. Image generated with BioRenderBack to article page